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This editorial refers to ‘Risk of arrhythmias in 52 755
long-distance cross-country skiers: a cohort study’†, by
K. Andersen et al., on page 3624
Exercise is one of the most powerful lifestyle intervention strategies
for the primary and secondary prevention of cardiovascular disease.
There is a wealth of evidence regarding the lower ranges of the exer-
cise dose–response relationship providing concrete evidence for the
current recommendationsof at least 30minofmoderate intensityex-
ercise on most days as a means of reducing cardiovascular events.1
However, there is an increasing proportion of today’s society en-
gaging in sports practices which vastly exceed these guidelines, and
there has been very limited study of the upper ranges of the exercise
dose–response relationship.2 Onthe onehand are studies suggesting
that long-term health and life expectancy of well-trained athletes is
superior to that of the general population,325 while, on the other,
there is evidence suggesting an increased prevalence of arrhythmias
and chronic structural remodelling of the athletic heart.629
Atrial fibrillation (AF) may therefore represent the most intriguing
and best evidenced example of the interplay between exercise and
cardiac health. AF can be diagnosed in 1% of the population by age
60 and in. 10%whenolder than80 years,10 making it themost preva-
lent sustained arrhythmia in adults. In cohorts of young or middle-aged
subjects, AF is relatively uncommon, thus implying that large cohorts
would be required to provide sufficient power to identify any excess
in prevalence due to sports practice. In this context, it is not surprising
thatPellicciaetal. foundonlyvery fewcasesofAFdespite significant left
atrial enlargement in a fairly large (n ¼ 1777) athletic cohort aged
24+6 years.11 In contrast, Baldesberger et al. were able to identify
an excess of AF when comparing a small cohort of 62 former profes-
sional cyclists with 62 ex-golfers aged 66+7 years.6 Although one
must always consider type 1 errors (false discoveries) in studies of
small sample size, it may also be that a true exercise-induced excess
in AF prevalence becomes appreciable when the cohort reaches an
age in which AF is more common and when the amount of exercise
practised is relatively extreme. In this context, the recent study of
Andersen et al. is remarkable.12 The group of participants in the
popular Vasaloppet 90 km cross-country ski race was young and
healthy when one considers the likelihood of identifying incident AF.
Less than10%of thecohortwasaged.60 years and thosewith signifi-
cant co-morbidities were few, as evidenced by the exclusion of parti-
cipants with known cardiovascular disease and by the fact that the
cohort had better health behaviour and overall longevity than the
average Swedish population.13 Many of the established risk factors
for AF, such as hypertension, heart failure, diabetes, and obesity,14
are likely to be under-represented within this group of cross-country
ski enthusiasts and, thus, we might expect such a low prevalence of AF
that detecting any residual risk attributable to exercise dose would be
difficult. However, the very large cohort size of 52 755 athletes and the
creative measures of exercise enabled the authors to define a ‘dose–
response’ curve that provides further circumstantial evidence for the
premise that AF risk is increased in the very fittest athletes and in
those who perform exercise over many years. Andersen et al. investi-
gated the primary endpoint of any arrhythmia, which was a composite
ofbrady- and tachyarrhythmias, and determined that those completing
the race within 60% of the winner’s time were 1.3 times more likely to
bediagnosedwithanarrhythmiathan thosewhotookmore thantwice
the time to complete the race. Similarly, those who had completed the
race ≥5 times had a 1.3-fold increase in arrhythmic risk as compared
with those who completed the race only once. The primary endpoint
was predominantly driven by AF, with a similar trend seen in bradyar-
rhythmias (though fewer events, making definitive conclusions diffi-
cult). There was no apparent association between exercise measures
and supraventricular arrhythmias other than AF/atrial flutter, and
therewere too few ventricular arrhythmic events todraw conclusions.
One of the biggest limitations when trying to interpret the data of
Andersen et al. is trying toworkout a reference point againstwhich to
interpret the described prevalence of arrhythmias. The lowestpreva-
lence of arrhythmias was observed in the slowest athletes who had
raced least; but what is the critical ‘cut-off’ concerning the amount
of exercise that leads to an elevated risk for developing AF? We
are frequently asked: ‘How many hours of exercise and at what
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intensity before I am at risk of AF?’, but there are numerous complex-
ities which make it difficult to give prescriptive guidelines. First, as
summarized in Figure1, arrhythmias such as AFare the clinical expres-
sion of an interplay between host, environmental, and disease-
specific factors. Host factors include age, gender, other genetic
factors (from single-gene mutations to multiple nucleotide poly-
morphisms), obesity, alcohol consumption, sleep apnoea, and
others.15 Disease-related factors include atrial stretch, autonomic
balance, and systemic and local inflammation, while environmental
factors include dietary factors, concurrent illnesses, and exercise.15
It is extremely difficult to define the magnitude of the risk attributable
to exercise in isolation. In particular, the influence of gender is an im-
portant case in point. A massive limitation of all exercise studies, in-
cluding that of Andersen et al., is the lack of data pertaining to
females. There is currently no evidence that sports’ training constitu-
tes a risk for AF in females, but this is largely due to the gross under-
representation of females in sports cardiology research.
Thesecond issue in trying todefineclinical recommendationsonthe
perfect amount of exercise to minimize the risk of arrhythmias relates
to the difficulties in comparing measures of exercise dose across
studies.Variousquestionnaireshavebeendevelopedtoassess thedur-
ation, frequency, and intensity of physical activity, but they remain fairly
coarse estimates for defining exercise exposure subject to consider-
able bias.16 For example, the subjective assessment of exercise inten-
sity is inversely associated with a person’s fitness, such that jogging, for
example,will be ratedas3/10 intensitybysomeoneofexcellentfitness,
but as7/10bysomeonewithpoorfitness.17 A similareffect canbeseen
when comparing literature across various disciplines; what is seen as
vigorous exertion in cardiovascular epidemiology studies would not
Figure 1 Interplay between environment, person, and disease
in the clinical expression of atrial fibrillation.
Figure 2 U-shaped relationship between the exercise dose and the relative risk of developing atrial fibrillation (AF). Composite data from three
separate trials along the x-axis demonstrating an association between reducing prevalence of AF with increasing exercise of low intensity but then an
increasing risk of AF with moderate and intense exercise. The echocardiogram examples above demonstrate the progressive cardiac remodelling
from a typical sedentary subject (left), a leasure-time athlete (middle), and a professional cyclist (right). The 10 cm marker on the echocardiogram is
highlighted with a red circle and the images have been scaled relative to this. The inference is that as exercise dose increases, the heart gets bigger and
the risk of AF increases. Whether or not there is a causal relationship between cardiac enlargement and arrhythmias is still to be determined.
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even be considered warm up tempo in sports science parlance.18 The
term ‘high intensity exercise’ can be used todescribe walking up aflight
of stairs in somestudies of AF18 or, in the caseof the study ofAndersen
et al.,12 can be applied to 90 km of cross-country ski racing. With this in
mind, we have tried to construct a ‘guestimate’ of relative exercise
doses in three landmark studies investigating the interaction
between exercise and AF incidence. Our best attempt at trying to in-
tegrate data across very disparate studies is presented in Figure 2. The
riskofAFdecreases asoneengages in regularphysical activityofmild to
moderate exertion, as evidenced by the study of elderly subjects by
Mozaffarian et al.19 However, as reported by Aizer et al., when the
level of exertion is equivalent to jogging, then a greater prevalence of
AF is appreciable in those jogging daily as compared with those
jogging 1–2 times/week.20 A reasonable ‘guestimate’ when consider-
ing the level of physical conditioning required to compete in the Vasa-
loppet ski race would suggest that Andersen et al. complete the
sporting spectrum by describing people mostly of moderate to ex-
tremely high physical conditioning. Thus, some picture of the exercise
dose–response curve emerges, with a U-shaped pattern suggesting
that regularmild tomoderateexercisemayprovideadegreeofprotec-
tion from AF while more sustained vigorous exertion represents a risk
factor. This is supported by a number of case–control studies which
have demonstrated a consistent association between endurance exer-
cise and AF/atrial flutter.6,21227 With considerable caveats noted,
these studies provide us with some idea to guide our answer regarding
the dose of exercise required to promote AF. Perhaps they also
provide a clinical clue that we should be advising our athletes with
AF to reduce their training intensity and volumes, but certainly not
to cease exercise practice all together. The wisdom of such advice
will really only be known after well-designed studies specifically
address the efficacy of such interventions.
Whilst the study of Andersen et al. helps to expand our understand-
ing of the epidemiology of exercise-induced arrhythmias, it does not
provide any insights into underlying mechanisms. However, recent
studies in animals and humans support the premise that exercise
may serve as a trigger, a modulator, and contribute to the underlying
substrate for the promotion of arrhythmias. A collaboration
between the Barcelona group of Lluis Mont and the Montreal group
of Stanley Nattel has demonstrated that a model of endurance training
in rats (the ‘marathon rat’) can be used to demonstrate increased in-
flammation and fibrosis, and enhanced vagal responsiveness affecting
the atria and right ventricle (curiously sparing the left ventricle)
whichpredisposestheanimals tobothAFandright ventriculararrhyth-
mias.28,29 This resembles some of the observations in human athletes.
Heidbuchel and La Gerche observed that endurance exercise can
promote remodelling and arrhythmias which seems to favour the
right ventricle disproportionately,8,9 whereas Luthi et al.,30 amongst
others, have demonstrated biatrial remodelling. The other intrigue
to which these studies are drawn is whether the remodelling asso-
ciated with exercise training (theso-called ‘athlete’s heart’) is anentire-
ly physiological process. As detailed in Figure 2, increasing exercise
training is associated with cardiac remodelling which can be profound.
It remains to be determined whether those athletes with the biggest
hearts are at greatest risk of arrhythmias.
Conflict of interest: none declared.
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